Anti-Factor IX & Factor X Refe
rence Antibody (Emicizumab Biosimilar)(BIO0318SM)-1mg/5mg/100ug- ￥2160 - 18900
- Bioss
- BIO0318SM
- 2025年10月10日
- 产品信息以Bioss网站为准
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 技术资料
- 应用范围：
产品信息以Bioss网站为准
- 规格：
1mg/5mg/100ug
| 规格： | 1mg | 产品价格： | ￥6000.0 |
|---|---|---|---|
| 规格： | 5mg | 产品价格： | ￥18900.0 |
| 规格： | 100ug | 产品价格： | ￥2160.0 |
| 产品编号 | BIO0318SM |
| 英文名称 | Anti-Factor IX & Factor X Reference Antibody (Emicizumab Biosimilar) |
| 英文别名 | F9 / Factor IX & Factor X / Fxa; Emicizumab |
| 产品应用 | ELISA, Bioactivity: FACS, Functional assay, Research in vivo Not yet tested in other applications. |
| 交叉反应 | Human |
| 亚型 | IgG-like |
| 性状 | Lyophilized |
| 纯化方法 | Protein A |
| 克隆类型 | Monoclonal |
| 理论分子量 | 145.62 kDa |
| 储存液 | 100 mM Pro-Ac 20mM Arg pH 5.0 |
| 保存条件 | -80°C for 2 years under sterile conditions； -20°C for 1 year under sterile conditions；Avoid repeated freeze-thaw cycles. |
| 注意事项 | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
| 应用 | 推荐稀释比例 |
Anti-CD3 & GD2 Reference Antibody (Nivatrotamab) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 95%.
Anti-CD3 & GD2 Reference Antibody (Nivatrotamab) is 100.00%, determined by SEC-HPLC.
Emicizumab bound to Factor IX protein, and then rebounded to secondary antibodies(Anti-Human-IgG-Fc-HRP) , and read OD450. As shown in fig, Emicizumab bound in human Factor IX Protein-His, and the EC50 was 2.296 nM.
Emicizumab bound to Factor X protein, and then rebounded to secondary antibodies(Anti-Human-IgG-Fc-HRP) , and read OD450. As shown in fig, Emicizumab bound in human Factor X Protein-His, and the EC50 was 2.033 nM.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
技术资料暂无技术资料 索取技术资料
Anti-Factor IX & Factor X Reference Antibody (Emicizumab Biosimilar)(BIO0318SM)-1mg/5mg/100ug
￥2160 - 18900
